Feng, Yu
Guo, Xiaonan
Huang, Peng
Jia, Ningning
Wang, Li
Ji, Xiaolong
Qin, Zeyu
Li, Meng
Lai, Jianbo
Qin, Xiaofeng
Yue, Weihua
Yang, Sheng
Hu, Shaohua https://orcid.org/0000-0003-0570-670X
Funding for this research was provided by:
National Natural Science Foundation of China (82173585)
National Natural Science Foundation of China (82571735)
Key R&D Program of Zhejiang Province (2025C02109, 2024C03098)
National Key Research and Development Program of China (2023YFC2506200)
Ningbo Key Research and Development Program (2025Z156)
Article History
Received: 16 January 2026
Accepted: 21 July 2026
First Online: 27 July 2026
Declarations
Ethics approval and consent to participate: Ethical approval for the CLASS-BD study was obtained in the single center of the First Affiliated Hospital of Zhejiang University School of Medicine. This study was approved by the Medical Research Ethics Committee of the First Affiliated Hospital of Zhejiang University School of Medicine (approval no. 2017-397; ClinicalTrials.gov NCT05480150), and written informed consent was obtained from each participant.
Consent for publication: Not applicable.
Competing interests: Jianbo Lai is a member of the BMC Medicine Editorial Board. The other authors declare that they have no competing interests.